Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine, Gemcitabine, and Docetaxel vs Paclitaxel and Carboplatin in Advanced NSCLC
NCT00079287Phase 3Completed
- Sponsor
- Japan Multinational Trial Organization
- Start
- Mar 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of vinorelbine, gemcitabine, docetaxel, paclitaxel, carboplatin in non-small cell lung cancer (NSCLC), sponsored by Japan Multinational Trial Organization. Started Mar 2001; status: completed.
02
Drugs
vinorelbinegemcitabinedocetaxelpaclitaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00079287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079287.